Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models

Can Hekim, Mette Ilander, Jun Yan, Erin Michaud, Richard Smykla, Markus Vaha-Koskela, Paula Savola, Siri Tahtinen, Leena Saikko, Akseli Hemminki, Panu E. Kovanen, Kimmo Porkka, Francis Y. F. Lee, Satu Mustjoki

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalCancer immunology research
Volume5
Issue number2
Pages (from-to)157-169
Number of pages13
ISSN2326-6066
DOIs
Publication statusPublished - Feb 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • CHRONIC MYELOID-LEUKEMIA
  • TYROSINE KINASE INHIBITOR
  • T-CELLS
  • COMBINATION IMMUNOTHERAPY
  • ANTITUMOR RESPONSES
  • NK-CELLS
  • IMATINIB
  • CANCER
  • MELANOMA
  • THERAPY
  • 3122 Cancers

Cite this